The Magnificent 8, the 10X Paradox, and What Coatue's Thomas Laffont Got Right About Private Markets

At the All-In Liquidity Summit on 4 June 2026, Thomas Laffont, co-founder of Coatue Management, made a claim that would have sounded implausible two years ago: SpaceX, OpenAI, and Anthropic alone will produce more exit value than all venture-backed exits from the prior decade combined. Not more than last year. More than the entire decade.

Anthropic filed its confidential S-1 on 1 June, three days before Laffont's presentation. OpenAI filed on 8 June. SpaceX listed on 12 June. The claim is now being tested in real time, and the early results are more complicated than a clean confirmation. We think the underlying data holds up better than the headlines from the past two weeks suggest.

The Magnificent 8

Laffont introduced what he called the "Magnificent 8": SpaceX, Stripe, Anthropic, Databricks, Revolut, ByteDance, Anduril, and OpenAI, a group of private companies with a combined valuation approaching $4 trillion that has, by his data, outperformed the public Nasdaq Magnificent 7 index since the first All-In Summit in September 2024. The diversity of the group matters as much as the scale. AI, fintech, space tech, enterprise software, defence. These are not companies in a single sector riding a single wave. They are dominant businesses across the most important verticals of the current decade, most of them still private.

"I'd feel pretty comfortable owning this index if I could for the next decade plus," Laffont said. The implied argument is not that these are venture bets waiting for an exit. It is that they are generational franchise businesses that will anchor institutional portfolios long after they list.

We think this framing is the most useful idea in the presentation, and it is worth being specific about why. Most private market commentary still treats individual company selection as the primary skill. Laffont's framing treats access to a defined set of category leaders as the primary skill, with individual stock-picking as a secondary concern once you are inside that set. For wholesale investors choosing between a diversified venture fund and a concentrated position in a small number of dominant private companies, that distinction should change how the decision gets made.

The 10X Paradox

The most counterintuitive part of Laffont's presentation was the data on return probability at each valuation tier.

• Conventional venture logic says earlier-stage bets carry the highest upside. The data says the opposite. A unicorn (valued above $1 billion) has an 8% probability of reaching $10 billion.
• A decacorn (above $10 billion) has a 13% probability of reaching $100 billion.
• But a centacorn, a company already valued above $100 billion, has a 31% probability of delivering another 10x return to $1 trillion.

The filtering mechanism explains it. "To get to that level, you have to have a dominant business," Laffont said. "And then the question is just at what point do you hit saturation." The companies that survive to centacorn status have already demonstrated durable earnings, compounding advantages, and the ability to defend their position. The further a company has already come, the more likely it is to keep going.

We think this is the single most useful data point in the presentation for a wholesale investor audience, because it directly contradicts the instinct that earlier and cheaper is always better. The instinct is not wrong as a general rule of venture investing. It is wrong specifically at the top of the market, where the companies that have already cleared the hardest filters are statistically more likely to keep compounding than a venture portfolio's median earlier-stage bet. For investors deciding between a basket of unicorns and a concentrated position in an already-dominant centacorn, the data argues for the latter more strongly than most private market marketing materials acknowledge.

The Unicorn Economy's Rebound

The broader private market context behind Laffont's thesis is that the unicorn economy has rebounded roughly 70% since September 2024, but the recovery is highly concentrated. Capital is flowing to a narrow group of winners rather than being spread across a large cohort of new companies.

This concentration mirrors the public market pattern where a small number of companies drive the majority of index returns. In private markets, the Magnificent 8 account for a disproportionate share of the total value created since 2024. The rest of the unicorn cohort has recovered more modestly.

For allocators, the concentration creates a specific problem. Broad-based exposure to private markets, through diversified VC funds or secondary positions across many names, will not necessarily capture the returns that make private markets compelling in this cycle. The return is concentrated in specific companies, not spread evenly across the asset class.

What Has Happened Since the Presentation

Laffont flagged two risks he described as unmodeled in his framework, and both have already started playing out, faster than his own estimates suggested.

1. Passive buying delay. Laffont estimated that index-driven buying pressure would take approximately six months post-IPO to clear before true price discovery set in. SpaceX listed on 12 June at $135, surged to $225.64 within four trading days as forced index buying took hold, then corrected by roughly 30% over the following two weeks. The price discovery process Laffont described as a six-month phenomenon began compressing into the stock's price within the first month.

2. Competitive dynamics between OpenAI and Anthropic. Laffont framed this as a post-2028 risk tied to balance sheet strength after both companies went public. What has happened instead is that the two companies have made opposite decisions about timing in direct response to the SpaceX correction. OpenAI is leaning toward delaying its IPO to 2027, holding out for a $1 trillion valuation rather than accepting a discount in the current market. Anthropic, by contrast, is pushing toward an October 2026 listing, treating the moment as an opportunity to set the public market pricing benchmark before OpenAI does. We think this divergence is a more interesting signal than either delay or rush would be on its own: it shows two well-resourced companies reading identical market data and reaching opposite conclusions about what it means for their own listings, which says more about company-specific conviction than about the broader market.

What This Means for Pre-IPO Investors Now

Laffont's framing is useful for investors who already hold pre-IPO positions in any of the Magnificent 8, because it changes the question from "should I have bought this?" to "what do I do now?"

The centacorn data suggests that companies already at scale have a high probability of continuing to compound. Selling immediately at IPO, into a market still working through index-driven price discovery, is unlikely to be the optimal exit for investors who do not need immediate liquidity. The SpaceX trading pattern over its first month supports this directly: investors who bought during the initial surge to $225 and held through the correction are in a different position than those who bought at the peak expecting the rally to continue.

For investors who don't yet hold positions, the window is not closing uniformly. Anthropic's October 2026 timeline is firmer than OpenAI's, which now depends on market conditions stabilising enough to support a $1 trillion valuation. Secondary positions in these companies, where available through regulated structures, remain one of the more reliable entry points before public market pricing takes over, but the timeline for each company needs to be tracked separately rather than treated as one undifferentiated "AI IPO wave."

As we covered in our guide to private market secondaries and what pre-IPO investors need to know ahead of the 2026 listings, the mechanics of how investors access these companies and at what price will matter more than simply having exposure.

We think Laffont's core thesis, that concentration in a small number of category-defining private companies beats diversification across the broader unicorn field, holds up well against the events of the past month. What the past month has added is a more precise picture of how messy the transition from private to public actually is for even the strongest companies in that group, and that is useful information for anyone deciding when and how to act on the thesis rather than a reason to doubt it.

NonPublic Pty Ltd (ABN 49 607 216 928) holds Australian Financial Services Licence #482668. Investments are available to wholesale and sophisticated investors as defined under the Corporations Act 2001. This content is general in nature and does not constitute financial product advice. It does not take into account your objectives, financial situation, or needs. Investing in private markets involves significant risk, including the potential loss of your entire investment. Past performance is not a reliable indicator of future results. You should obtain independent financial advice before making any investment decision.